Professional Documents
Culture Documents
STEMI EXTENSIVE
ANTERIOR KILLIP I
Presented by :
Herin Arini Natalia
Supervisor :
Dr.dr.Idar
Mappangara,Sp.PD,Sp.JP.FIHA.FINASIM
PATIENT IDENTITY
MR number
: 632700
Name
: Mrs. S
Age
: 56 years
old
Date administered : October
15th 2013
History Taking
Chief complaint: Chest pain
History of hypertension ( + )
Risk Factors
Modifiable
Physical Examination
General status
Moderate illness/well
nourished/conscious
Vital sign
BP: 140 / 80 mmHg
HR : 68 x/min
RR : 28 x/min
T
: 36.80 C
Regional Status
Head Examination
o
o
o
Thoracal Examination
o
o
o
o
Regional Status
Heart Examination
o Inspection : IC wasnt visible
o Palpation : IC wasnt palpable
o Percussion : normal heart size
Upper border : left 2nd ICS
Lower border : left 5th ICS
Right border
: right parasternalis line
Left border : left medioclavicular line
o Auscultation : Regular of I/II heart sound, murmur (-)
Abdominal Examination
o
o
o
o
Extremities
o
Oedema
Electrocardiography
(ECG)
Interpretation
Rhythm : Sinus
Heart rate : 60 bpm
Regularity : reguler
Axis : Normoaxis, 45
P wave : 0,08 s
PR interval
: 0,16 s
QRS wave
: Q patologis V1-V3, durasi
0,08 s
ST Segment : ST elevation Lead I, AVL, V2-V5
T wave : T inverted V1
Conclusion : STEMI extensive anterior
Blood chemistry
Laboratory Examination
Random blood sugar: 329
mg/dl
Complete blood
WBC
: 11.5 x 103 /mm3
()
HGB
: 12.3 g/dl
HCT
: 36. 3 %
RBC
: 4.09 x 106 /mm3
PLT
: 169 x 103 /mm3
Cardiac enzyme
CK
: 131
CK MB : 24 u/L
Troponin T: < 0.02
Electrolyte
Sodium
:137 mmol/l
Potassium
: 3.78 mmol/l
Chloride : 106 mmol/l
SGOT
: 33 u/l
SGPT
: 42 u/l
Ureum : 26
Creatinin : 0.6
PT
: 8.8
APTT
: 19.9
: 35 mg/dl
LDL
: 122 mg/dl
Triglyseride
Uric acid
: 177 mg/dl
: 3.5
WORKING DIAGNOSIS
STEMI Extensive Anterior
onset 3 jam, KILLIP I
Management
Bed rest
Nitrat
Cedocard 2 mg/jam/SP
Trombolytic
HMG-Co A reductase
inhibitor (Simvastatin 1 x
20 mg)
Anxiolytic
2 mg/iv
Anti cholesterol
Captopril 3x6,25 mg
Morfin
ACE-inhibitor
Benzodiazepin
(Alprazolam) 0,5 mg - 0
-1
Laxative
DISCUSSION
ACUTE CORONARY
SYNDROME
(ST SEGMENT Elevation
Myocardial Infarction)
ANATOMY
PATHOPHYSIOLOGY
STEMI generally occurs when
coronary blood flow decreases
abruptly after a thrombotic
occlusion of a coronary artery
previously affected by
atherosclerosis.
In most cases, infarction occurs
when an atherosclerotic plaque
fissures, ruptures, or ulcerates
and when condition favor
thrombogenesis.
Definition
Acute Coronary Syndrome (ACS) is a term for
situations where the blood supplied to the heart muscle is
suddenly blocked.
describe a group of conditions resulting from acute
myocardial ischemia (insufficient blood flow to heart
muscle)
ranging from unstable angina (increasing,
unpredictable chest pain) to myocardial
infarction (heart attack).
CLASSIFICATION
RISK
FACTOR
CLINICAL MANIFESTATION
WHO Diagnostic
Criteria
1.
2.
3.
Clinical history of
ischaemic
type
chest pain lasting
>20 minutes
Changes in serial
ECG tracings
Rise and fall of
serum
cardiac
biomarkers such as
creatinine kinase-MB
fraction and troponin
ELECTROCARDIOGRAM
SERUM CARDIAC
BIOMARKERS
CK-MB
MARKERS
AFTER ACUTE MYOCARDIAL
INFARCTION (AMI).
MANAGEMENT
Fixing the chest pain and fearness
o Bed rest
o Diet
o O2 2-4 lpm via nasal prongs or face mask
o Sublingual/oral/IV nitroglycerine
o Antiplatelet: aspirin and clopidogrel
o Morfin/petidine
o Diazepam 2-5mg/8 hour
Stabilizing the hemodynamic (blood pressure and peripheral
pulse control)
o -blocker if theres no contraindication
o Calcium channel blocker (CCB)
o ACE-Inhibitor
Reperfusion of the myocard
o Thrombolytict
Class
I
II
III
IV
Mortality Rate
(%)
Description
no clinical signs of heart
failure
rales or crackles in the lungs,
an S3, and elevated jugular
venous pressure
acute pulmonary edema
cardiogenic shock or
hypotension (systolic BP < 90
mmHg), and evidence of
peripheral vasoconstriction
6
17
30 - 40
60 80
KILLIP CLASSIFICATION
PROGNOSIS
PREVENTION